Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug

References

• Abdel-Hafez SM, Hathout RM, Sammour OA. (2014). Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs. Int J Biol Macromol 64:334–40
   PubMed Web of Science ®Google Scholar
• Abuhanoglu G, Ûzer A. (2014). Radiation sterilization of new drug delivery systems. Inter Med Appl Sci 6:51–60
   PubMedGoogle Scholar
• Attia Shafie MA, Hassan Rady MA. (2012). In vitro and In vivo Evaluation of Timolol Maleate Ocular Inserts Using Different Polymers. J Clin Exp Ophthalmol 3:246
   Google Scholar
• Box GEP, Cox DR. (1964). An analysis of transformations. J Royal Stat Soc S B (Methodological) 26:211–52
   Google Scholar
• Cevc G, Blume G, Schatzlein A, et al. (1996). The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 18:349–78
   Web of Science ®Google Scholar
• Cevc G. (2012). Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J Control Release 160:135–46
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 1514:191–205
   PubMed Web of Science ®Google Scholar
• Cevc G, Schatzlein A, Richardsen H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564:21–30
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. (2010). Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 141:277–99
   PubMed Web of Science ®Google Scholar
• Chan J, El Maghraby GM, Craig JP, Alany RG. (2008). Effect of water-in-oil microemulsions and lamellar liquid crystalline systems on the precorneal tear film of albino New Zealand rabbits. Clin Ophthalmol 2:129
   PubMedGoogle Scholar
• Chopra A, Cevc G. (2014). Non-invasive, epicutaneous immunisation with toxoid in deformable vesicles protects mice against tetanus, chiefly owing to a Th2 response. Eur J Pharm Sci 56:55–64
   PubMed Web of Science ®Google Scholar
• El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharmaceut 158:121–7
   Web of Science ®Google Scholar
• Elbialy NS, Abdol-Azim BM, Shafaa MW, et al. (2013). Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. J Biomed Nanotechnol 9:2105–16
   PubMed Web of Science ®Google Scholar
• Fagir W, Hathout RM, Sammour OA, ElShafeey AH. (2015). Self-microemulsifying systems of Finasteride with enhanced oral bioavailability: multivariate statistical evaluation, characterization, spray-drying and in vivo studies in human volunteers. Nanomedicine (Lond) 10:3373–89
   PubMed Web of Science ®Google Scholar
• Friedman Z, Allen RC, Raph SM. (1985). Topical acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol 103:963–6
   PubMed Web of Science ®Google Scholar
• Galdston M. (1955). Respiratory and renal effects of a carbonic anhydrase inhibitor (Diamox) on acid-base balance in normal man and in patients with respiratory acidosis. Am J Med 19:516–32
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharmaceut 306:71–82
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1–E12
   PubMed Web of Science ®Google Scholar
• Hathout RM, Omran MK. (2016). Gelatin-based particulate systems in ocular drug delivery. Pharm Dev Technol 21:379–86
   PubMed Web of Science ®Google Scholar
• Hughes B, Feiz V, Flynn SB, Brodsky MC. (2004). Reversible amantadine-induced corneal edema in an adolescent. Cornea 23:823–4
   PubMed Web of Science ®Google Scholar
• Jain V, Kare P, Jain D, Singh R. (2011). Development and characterization of mucoadhesive nanosuspension of ciprofloxacin. SEM 5:9
   Google Scholar
• Khan MA, Pandit J, Sultana Y, et al. (2015). Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv 22:795–802
   PubMed Web of Science ®Google Scholar
• Kodaka H, Mizuochi S, Teramura H, Nirazuka T. (2005). Comparison of the compact dry TC method with the standard pour plate method (AOAC Official Method 966.23) for determining aerobic colony counts in food samples: performance-tested methodSM. J AOAC Int 88:1702–13
   PubMed Web of Science ®Google Scholar
• Manconi M, Caddeo C, Sinico C, et al. (2012). Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm 82:352–9
   PubMed Web of Science ®Google Scholar
• Mehanny M, Hathout RM, Geneidi AS, Mansour S. (2016). Bisdemethoxycurcumin loaded polymeric mixed micelles as potential anti-cancer remedy: preparation, optimization and cytotoxic evaluation in a HepG-2 cell model. J Molec Liquids 214:162–70
   Web of Science ®Google Scholar
• Mishra D, Garg M, Dubey V, et al. (2007). Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 96:145–55
   PubMed Web of Science ®Google Scholar
• Mishra GP, Bagui M, Tamboli V, Mitra AK. (2011). Recent applications of liposomes in ophthalmic drug delivery. J Drug Deliv 2011:863734:1–14
   Google Scholar
• Mura S, Manconi M, Sinico C, et al. (2009). Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharmaceut 380:72–9
   PubMed Web of Science ®Google Scholar
• Olah Z, Veselovsky J, Gressnerova S, Vesela A. (2005). IOP in rabbits after instillation of a mixture of the antiglaucomatic Cosopt and the aminoacid L-argininin HCL into the conjunctival sac. Ceska a Slovenska Oftalmologie 61:3–12
   PubMedGoogle Scholar
• Paul S, Mondol R, Ranjit S, Maiti S. (2010). Anti-glaucomatic niosomal system: recent trend in ocular drug delivery research. Int J Pharm Pharmaceut Sci 2:15–18
   Google Scholar
• Pisal PB, Joshi MA, Padamwar MN, et al. (2014). Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation. Int J Pharmaceutics 461:82–8
   PubMed Web of Science ®Google Scholar
• Rathore KS, Nema RK. (2009). An insight into ophthalmic drug delivery system. Int J Pharm Sci Drug Res 1:1–5
   Google Scholar
• Safwat S, Hathout RM, Ishak RA, Mortada ND. (2016). Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment. J Liposome Res. [Epub ahead of print]. doi:10.3109/08982104.2015.1137313
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54
   PubMed Web of Science ®Google Scholar
• Shen Y, Jin E, Zhang B, et al. (2010). Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. Am Chem Soc 132:4259–65
   PubMed Web of Science ®Google Scholar
• Singh HP, Utreja P, Tiwary AK, Jain S. (2009). Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 11:54–64
   PubMed Web of Science ®Google Scholar
• Singla AK, Kaur IP, Garg A, Aggarwal D. (2002). Novel approaches for topical delivery of acetazolamide. Pharmaceut Technol 26:24–35
   Google Scholar
• Soliman SM, Abdelmalak NS, El-Gazayerly ON, Abdelaziz N. (2016). Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits. Drug Deliv 23:1608–22
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock RE. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols 3:163–75
   PubMed Web of Science ®Google Scholar
• Youshia J, Kamel AO, ElShamy A, Mansour S. (2012). Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide. Int J Nanomedicine 2012:2483–96
   Google Scholar